作者: Manuela Neri , Bruno Piras , Anna Maria Paoletti , Valerio Vallerino , Valentina Corda
DOI: 10.1080/09513590.2017.1416465
关键词:
摘要: AbstractThis observational study was conducted in healthy premenopausal women, who presented themselves for contraception with an intrauterine system (IUS) releasing LNG (6 mcg/d) (Jaydess®, Bayer, Germany) at the outpatient Family Planning Clinics of Departments Obstetrics and Gynaecology Universities Cagliari Sassari (CA/SS), University-Hospitals CA/SS (Italy). After a screening visit, 31 women without contraindications to Jaydess® were included study. No difficulty insertion (Ji) found 87% subjects, pelvic pain (PP) (visual analogic scale, VAS:5.33 ± 2.54) reported by 27/31 subjects Ji. Pelvic 17/31 on first day (VAS: 3.07 ± 3.1), 16/31 second (VAS:2.37 ± 2.71), 11/31 third (VAS:1.18 ± 2.02) from Ji, significant (p < .001) decrease intensity. The primary purposes evaluate whether 12-month-treatment (12-M-T) inte...